Flecainide (acetate) Reference: 20388-50 An inhibitor of cardiac late INa channels (IC50 = 3.4 µM) and IKr channels (IC50 = 1.5 µM); used clinically to suppress arrhythmias and sodium-dependent calcium overload associated with myocardial ischemia and heart failure
Ramelteon Reference: 20389-10 A melatonin receptor agonist (Kis = 14, 112, and 23.1 pM for human MT1, human MT2, and chick forebrain receptors, respectively); selective for MT1 and MT2 over MT3 receptors (Ki = 2.65 μM for hamster brain MT3 receptors) as well as a panel of benzodiazepine, dopamine, and opiate receptors, ion channels, transporters, and enzymes when used at a concentration of 10 μM; stimulates cAMP production in CHO cells expressing human MT1 and MT2 receptors (IC50s = 21.2 and 53.4 pM, respectively); shortens latency to sleep onset and increases duration of sleep in free moving crab-eating macaques at 0.03 and 0.3 mg/kg; accelerates reentrainment of circadian rhythm in rats at 0.1 and 1 mg/kg,
Ramelteon Reference: 20389-25 A melatonin receptor agonist (Kis = 14, 112, and 23.1 pM for human MT1, human MT2, and chick forebrain receptors, respectively); selective for MT1 and MT2 over MT3 receptors (Ki = 2.65 μM for hamster brain MT3 receptors) as well as a panel of benzodiazepine, dopamine, and opiate receptors, ion channels, transporters, and enzymes when used at a concentration of 10 μM; stimulates cAMP production in CHO cells expressing human MT1 and MT2 receptors (IC50s = 21.2 and 53.4 pM, respectively); shortens latency to sleep onset and increases duration of sleep in free moving crab-eating macaques at 0.03 and 0.3 mg/kg; accelerates reentrainment of circadian rhythm in rats at 0.1 and 1 mg/kg,
Ramelteon Reference: 20389-5 A melatonin receptor agonist (Kis = 14, 112, and 23.1 pM for human MT1, human MT2, and chick forebrain receptors, respectively); selective for MT1 and MT2 over MT3 receptors (Ki = 2.65 μM for hamster brain MT3 receptors) as well as a panel of benzodiazepine, dopamine, and opiate receptors, ion channels, transporters, and enzymes when used at a concentration of 10 μM; stimulates cAMP production in CHO cells expressing human MT1 and MT2 receptors (IC50s = 21.2 and 53.4 pM, respectively); shortens latency to sleep onset and increases duration of sleep in free moving crab-eating macaques at 0.03 and 0.3 mg/kg; accelerates reentrainment of circadian rhythm in rats at 0.1 and 1 mg/kg,
Racecadotril Reference: 20390-1 An enkephalinase inhibitor that prevents the degradation of endogenous opioids
Racecadotril Reference: 20390-100 An enkephalinase inhibitor that prevents the degradation of endogenous opioids